 Arek Wiktor
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 21 | 2026 | 374 | 6.200 |
Why?
| | Burn Units | 8 | 2025 | 41 | 1.750 |
Why?
| | Debridement | 2 | 2026 | 85 | 1.060 |
Why?
| | Patient Transfer | 3 | 2022 | 211 | 1.010 |
Why?
| | Triage | 2 | 2020 | 252 | 0.990 |
Why?
| | Mobile Applications | 2 | 2020 | 198 | 0.980 |
Why?
| | Blood Component Transfusion | 1 | 2026 | 104 | 0.890 |
Why?
| | Fluid Therapy | 1 | 2026 | 154 | 0.860 |
Why?
| | Occupational Therapists | 1 | 2024 | 9 | 0.850 |
Why?
| | Pyoderma Gangrenosum | 1 | 2024 | 8 | 0.840 |
Why?
| | Plasma | 1 | 2026 | 225 | 0.830 |
Why?
| | Cephalosporins | 1 | 2024 | 48 | 0.810 |
Why?
| | Resuscitation | 2 | 2026 | 311 | 0.810 |
Why?
| | Physical Therapists | 1 | 2024 | 64 | 0.770 |
Why?
| | Hypnotics and Sedatives | 1 | 2025 | 224 | 0.770 |
Why?
| | Pseudomonas Infections | 1 | 2024 | 230 | 0.710 |
Why?
| | Job Satisfaction | 1 | 2024 | 237 | 0.710 |
Why?
| | Renal Insufficiency | 1 | 2023 | 172 | 0.680 |
Why?
| | Pseudomonas aeruginosa | 1 | 2024 | 395 | 0.660 |
Why?
| | Hematoma, Epidural, Cranial | 1 | 2019 | 6 | 0.600 |
Why?
| | Respiratory Aspiration | 1 | 2019 | 32 | 0.580 |
Why?
| | Intraoperative Care | 1 | 2019 | 63 | 0.570 |
Why?
| | Patient Care Team | 1 | 2024 | 696 | 0.560 |
Why?
| | Intraoperative Complications | 1 | 2019 | 157 | 0.530 |
Why?
| | Remote Consultation | 1 | 2018 | 66 | 0.520 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2023 | 663 | 0.500 |
Why?
| | Enteral Nutrition | 1 | 2019 | 217 | 0.490 |
Why?
| | Energy Intake | 1 | 2019 | 506 | 0.470 |
Why?
| | Retrospective Studies | 13 | 2026 | 17269 | 0.440 |
Why?
| | Anti-Bacterial Agents | 2 | 2024 | 1953 | 0.410 |
Why?
| | Adult | 16 | 2026 | 40707 | 0.360 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2018 | 389 | 0.340 |
Why?
| | Skin Transplantation | 2 | 2024 | 85 | 0.340 |
Why?
| | Middle Aged | 14 | 2026 | 36176 | 0.300 |
Why?
| | Humans | 28 | 2026 | 145491 | 0.270 |
Why?
| | Critical Care | 3 | 2021 | 703 | 0.270 |
Why?
| | Male | 18 | 2026 | 72817 | 0.270 |
Why?
| | Female | 18 | 2026 | 78763 | 0.250 |
Why?
| | Angiotensin II | 1 | 2025 | 98 | 0.220 |
Why?
| | Vasoconstrictor Agents | 1 | 2025 | 150 | 0.210 |
Why?
| | tau Proteins | 1 | 2025 | 115 | 0.210 |
Why?
| | Dysbiosis | 2 | 2024 | 187 | 0.210 |
Why?
| | Subcutaneous Tissue | 1 | 2024 | 26 | 0.210 |
Why?
| | Quality Improvement | 2 | 2024 | 1294 | 0.210 |
Why?
| | Glycerophospholipids | 1 | 2024 | 39 | 0.200 |
Why?
| | Efficiency | 1 | 2024 | 104 | 0.200 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2024 | 81 | 0.200 |
Why?
| | Central Nervous System | 1 | 2025 | 282 | 0.190 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2025 | 181 | 0.190 |
Why?
| | Piperacillin | 1 | 2023 | 7 | 0.190 |
Why?
| | Analgesics | 1 | 2025 | 233 | 0.190 |
Why?
| | Shock, Septic | 1 | 2025 | 226 | 0.190 |
Why?
| | Length of Stay | 2 | 2026 | 1348 | 0.180 |
Why?
| | Frostbite | 1 | 2022 | 22 | 0.170 |
Why?
| | Creatinine | 1 | 2023 | 513 | 0.170 |
Why?
| | Bacteremia | 1 | 2024 | 223 | 0.170 |
Why?
| | Delirium | 1 | 2023 | 105 | 0.170 |
Why?
| | Bone and Bones | 1 | 2024 | 318 | 0.170 |
Why?
| | Cooperative Behavior | 1 | 2024 | 464 | 0.170 |
Why?
| | Pain Management | 1 | 2025 | 411 | 0.170 |
Why?
| | Salvage Therapy | 1 | 2022 | 165 | 0.160 |
Why?
| | Feces | 1 | 2024 | 514 | 0.160 |
Why?
| | Thrombolytic Therapy | 1 | 2022 | 166 | 0.160 |
Why?
| | Aged | 9 | 2025 | 26125 | 0.160 |
Why?
| | Oxygen | 1 | 2025 | 986 | 0.150 |
Why?
| | Tissue Plasminogen Activator | 1 | 2022 | 249 | 0.150 |
Why?
| | Glomerular Filtration Rate | 1 | 2023 | 765 | 0.150 |
Why?
| | Pain | 1 | 2025 | 787 | 0.150 |
Why?
| | Skin | 1 | 2024 | 766 | 0.140 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 297 | 0.140 |
Why?
| | Biomarkers | 3 | 2025 | 4283 | 0.140 |
Why?
| | Delayed Diagnosis | 1 | 2019 | 100 | 0.140 |
Why?
| | Hepcidins | 1 | 2018 | 21 | 0.140 |
Why?
| | Intubation, Gastrointestinal | 1 | 2019 | 81 | 0.140 |
Why?
| | Antibodies, Bacterial | 1 | 2018 | 147 | 0.130 |
Why?
| | Health Services Research | 1 | 2020 | 392 | 0.130 |
Why?
| | Immunity, Humoral | 1 | 2018 | 120 | 0.130 |
Why?
| | Pneumococcal Vaccines | 1 | 2018 | 129 | 0.130 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 368 | 0.130 |
Why?
| | Alcohol Drinking | 1 | 2024 | 837 | 0.120 |
Why?
| | Anemia | 1 | 2018 | 190 | 0.120 |
Why?
| | Analgesics, Opioid | 1 | 2025 | 1150 | 0.120 |
Why?
| | Neurosurgical Procedures | 1 | 2018 | 203 | 0.120 |
Why?
| | Intubation, Intratracheal | 1 | 2019 | 326 | 0.120 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1369 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2024 | 774 | 0.120 |
Why?
| | Alcoholism | 1 | 2023 | 821 | 0.120 |
Why?
| | Kidney | 1 | 2023 | 1498 | 0.110 |
Why?
| | Intensive Care Units | 1 | 2021 | 925 | 0.110 |
Why?
| | Young Adult | 3 | 2024 | 14192 | 0.110 |
Why?
| | Hypercapnia | 1 | 2015 | 53 | 0.110 |
Why?
| | Acid-Base Imbalance | 1 | 2014 | 3 | 0.110 |
Why?
| | Feasibility Studies | 1 | 2019 | 1119 | 0.100 |
Why?
| | Fatal Outcome | 1 | 2015 | 306 | 0.100 |
Why?
| | Immunoglobulin G | 1 | 2018 | 890 | 0.100 |
Why?
| | Palliative Care | 1 | 2021 | 1017 | 0.100 |
Why?
| | Healthcare Disparities | 1 | 2019 | 739 | 0.090 |
Why?
| | Influenza, Human | 1 | 2018 | 623 | 0.090 |
Why?
| | Institutionalization | 1 | 2011 | 12 | 0.080 |
Why?
| | Telemedicine | 1 | 2020 | 960 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1101 | 0.080 |
Why?
| | Acute Kidney Injury | 1 | 2018 | 873 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2020 | 8326 | 0.080 |
Why?
| | Geriatric Assessment | 1 | 2011 | 238 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2772 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2025 | 11831 | 0.070 |
Why?
| | United States | 3 | 2019 | 16115 | 0.060 |
Why?
| | Multivariate Analysis | 2 | 2023 | 1544 | 0.060 |
Why?
| | Developed Countries | 1 | 2025 | 38 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 125 | 0.060 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 79 | 0.060 |
Why?
| | Patient Discharge | 1 | 2011 | 992 | 0.050 |
Why?
| | Critical Illness | 2 | 2023 | 901 | 0.050 |
Why?
| | Time Factors | 1 | 2015 | 7171 | 0.050 |
Why?
| | Fatty Acids, Volatile | 1 | 2024 | 60 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2025 | 607 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 34 | 0.050 |
Why?
| | Acetaminophen | 1 | 2025 | 266 | 0.050 |
Why?
| | Microbial Sensitivity Tests | 1 | 2023 | 378 | 0.040 |
Why?
| | Age Factors | 2 | 2020 | 3340 | 0.040 |
Why?
| | Extremities | 1 | 2022 | 141 | 0.040 |
Why?
| | Adolescent | 1 | 2020 | 22485 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 667 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2025 | 1044 | 0.040 |
Why?
| | APACHE | 1 | 2018 | 68 | 0.030 |
Why?
| | Hypoxia | 1 | 2025 | 1199 | 0.030 |
Why?
| | Erythropoietin | 1 | 2018 | 100 | 0.030 |
Why?
| | Renal Replacement Therapy | 1 | 2018 | 100 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 195 | 0.030 |
Why?
| | Frailty | 1 | 2020 | 204 | 0.030 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2018 | 158 | 0.030 |
Why?
| | Iron | 1 | 2018 | 359 | 0.030 |
Why?
| | Prospective Studies | 2 | 2018 | 8039 | 0.030 |
Why?
| | Surgical Procedures, Operative | 1 | 2018 | 272 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 2054 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1268 | 0.030 |
Why?
| | California | 1 | 2014 | 483 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 6070 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2110 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4572 | 0.020 |
Why?
| | Child | 2 | 2025 | 22680 | 0.020 |
Why?
| | Frail Elderly | 1 | 2011 | 136 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2011 | 202 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2425 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5891 | 0.020 |
Why?
| | Inflammation | 1 | 2018 | 2883 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2129 | 0.010 |
Why?
| | Hospitalization | 1 | 2014 | 2458 | 0.010 |
Why?
| | Cohort Studies | 1 | 2011 | 5992 | 0.010 |
Why?
| | Risk Factors | 1 | 2011 | 10874 | 0.010 |
Why?
|
|
Wiktor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|